Clinical Trials Sponsored by Chiesi USA, Inc.

Total 758 results

Spectral Diagnostics (US) Inc.

Recruiting

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study (TIGRIS)

Septic Shock | Endotoxemia

United States
RVAC Medicines (US), Inc.

Terminated

Safety and Immunogenicity of RVM-V001 in Healthy Individuals Previously Vaccinated With BNT162b2 and mRNA-1273

COVID-19 | Infectious Disease

Australia
EuroPharma, Inc.
Botalys SA

Completed

Ginseng HRG80 in Stress and Fatigue

Psychological Stress

Armenia
Lisichansk Regional Tuberculosis Dispensary
National Medical University, Ukraine; Immunitor USA Inc.

Completed

Safety and Efficacy of Oral Immunomodulator in Tuberculosis (TB) and TB/HIV Patients

Tuberculosis

Ukraine
National Cancer Centre, Singapore
Bristol-Myers Squibb; OncoQuest Pharma USA Inc.

Unknown

Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin (ORION-02)

Epithelial Ovarian Cancer

Singapore
Biomat USA, Inc.
Axio Research. LLC; Hammond Clinical Trial Consulting, LLC

Completed

Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization Program

Healthy

United States
Icahn School of Medicine at Mount Sinai
Asahi Intecc USA Inc

Completed

SURE 18 Registry -Asahi Chikai Black 18 in LVO Stroke

Occlusive Stroke

United States
TD Vaccines A/S
Johns Hopkins University; Pierrel Research USA, Inc.

Completed

ACE527 Safety and Immunogenicity Study

Enterotoxigenic E. Coli (ETEC) Infection

United States
RVAC Medicines (US), Inc.

Terminated

Safety & Immunogenicity of RVM-V001/RVM-V002 or RVMV001+RVMV002 (Co Administered as Separate Injections) in Healthy Individuals

COVID-19 | Infectious Disease

Singapore
Harbour BioMed US, Inc.

Completed

A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of a Study Drug in Subjects With Advanced Solid Tumors

Advanced Solid Tumor

Australia, China, Hong Kong
Mitotech, SA
ORA, Inc.

Completed

Study of SkQ1 as Treatment for Dry-eye Syndrome (VISTA-1)

Dry Eye Syndrome

United States
Spectral Diagnostics (US) Inc.

No longer available

Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19

Septic Shock | Endotoxemia | COVID | Corona Virus Infection | Sepsis, Severe

United States
Harbour BioMed US, Inc.

Not yet recruiting

A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of HBM1020 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor
US Endoscopy Group Inc.

Completed

trūFreeze® Palliative Esophageal Cancer

Esophageal Cancer

United States
US Endoscopy Group Inc.

Completed

trūFreeze® Spray Cryotherapy Patient Registry

Barrett Esophagus | Esophageal Neoplasm | Esophageal Stenosis | Esophageal Dysplasia | Bronchial Neoplasm | Stenosis of Bronchus or Trachea

United States
Mitotech, SA
ORA, Inc.

Completed

Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome (VISTA-2)

Dry Eye Syndrome

United States
Spectral Diagnostics (US) Inc.

Temporarily not available

Open-label Evaluation of Polymyxin B Hemoperfusion for Septic Shock (EUPHORIA)

Septic Shock | Endotoxemia
Mitotech, SA
ORA, Inc.

Completed

A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)

Keratoconjunctivitis Sicca

United States
Spectral Diagnostics (US) Inc.

Completed

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock (EUPHRATES)

Septic Shock | Endotoxemia

United States, Canada
Cytheris SA
Cytheris, Inc.

Terminated

Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer

Kidney Cancer | Melanoma (Skin)

United States
Us Helping Us, People Into Living, Inc.

Not yet recruiting

Predictors of Health Service Utilizations Among Key Population in Washington DC

HIV | Health Behavior | Pre-exposure Prophylaxis
Research in Real-Life Ltd
Teva Pharmaceuticals USA

Unknown

The Clinical Profile of UK Asthma Patients With Raised Blood Eosinophils

Asthma

United Kingdom
Celgene
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...

Recruiting

Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia

Beta-Thalassemia

United States, Turkey, Italy, Thailand, Germany, Greece, China, India, Lebanon
Celgene
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...

Completed

A Study to Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia (BEYOND)

Thalassemia

United States, Greece, Italy, Lebanon, Thailand, United Kingdom
Us Helping Us, People Into Living, Inc.

Recruiting

SNS and PrEP Initiation and Adherence in Black SMM

HIV

United States
Celgene
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...

Completed

A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sotatercept (ACE-011) for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis.

Anemia

United States
Celgene
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...

Active, not recruiting

A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Participants Who Require Red Blood Cell Transfusions and Are ESA Naïve (COMMANDS)

Myelodysplastic Syndromes

United States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Lithuania, Netherlands, Poland, Portugal, Russian Federation, Spain, Sweden, Switzerland, Taiwan, Turke... and more
Millendo Therapeutics US, Inc.

Terminated

Nevanimibe HCl for the Treatment of Classic CAH

Congenital Adrenal Hyperplasia

Spain, Israel, France, Brazil, Czechia
Astellas Pharma Inc
Astellas Pharma US, Inc.

Terminated

A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States, Canada
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

Melanoma

United States
Astellas Pharma Inc
Astellas Pharma US, Inc.

Terminated

A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

Kidney Transplantation

United States
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy

Prostate Cancer | Cancer of the Prostate | Prostatic Cancer | Cancer of Prostate

Netherlands, United States, United Kingdom
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

Optimizing Prograf® Therapy in Renal Transplant Patients (OPTIMA)

Renal Transplantation

United States
BC Centre on Substance Use
Indivior Inc.

Recruiting

Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose (FASTER-BUP)

Opioid Overdose | Opioid-Use Disorder

Canada
Inova Health Care Services
DUSA Pharmaceuticals, Inc.

Completed

Photodynamic Therapy for Prevention of Nonmelanoma Skin Cancer in Organ Transplant Recipients (PDT)

Nonmelanoma Skin Cancers

United States
Duke University
National Institute on Drug Abuse (NIDA); Philip Morris USA, Inc.

Completed

Combination Bupropion / Varenicline for Smoking Cessation in Male Smokers (ConNic5)

Nicotine Dependence

United States
Tibotec, Inc
Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

Completed

Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment

HIV

United States
Tibotec, Inc
Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

Completed

GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.

HIV | Infectious

United States, Canada, Puerto Rico
Tibotec, Inc
Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

Completed

A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients (INROADS)

Human Immunodeficiency Virus (HIV)

United States, Puerto Rico
Tibotec, Inc
Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

Completed

A Phase I, Open-label Trial to Explore the Pharmacokinetics, Safety and Tolerability of TMC278 (Rilpivirine) 25 mg Once Daily Following a 2-week Period Receiving Efavirenz, in Healthy Male and Female Volunteers

HIV
Millendo Therapeutics US, Inc.

Terminated

A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome

Cushing Syndrome

United States, United Kingdom
BioNTech US Inc.
Apexigen, Inc.

Terminated

A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma

Metastatic Melanoma

United States
Midatech Pharma US Inc.
PharPoint Research, Inc.

Terminated

Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients

Oral Mucositis

United States
Astellas Pharma Inc
Astellas Pharma US, Inc.

Terminated

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Prostatic Neoplasms | Hormone-Refractory Prostate Cancer

United States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

Psoriasis

United States, Canada
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

A Study to Evaluate the Effects of YM872 on Stroke Lesion Volume in Acute Stroke Patients

Cerebrovascular Accident

Canada, Belgium, United States, Germany, South Africa, Austria
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)

Acute Ischemic Stroke

Canada, United States, Germany, Belgium, Austria
Cullinan Oncology Inc.
Harbour BioMed US, Inc.

Recruiting

CLN-418 Study on Subjects With Advanced Solid Tumors

Advanced Solid Tumor

Australia, United States
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

YM443 in Subjects With Functional Dyspepsia

Nausea | Indigestion

United States
Astellas Pharma Inc
Astellas Pharma US, Inc.

Terminated

YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer

Prostate Cancer

Belgium, Czech Republic, France, Germany, Poland, Spain, United Kingdom

Clinical Trials Sponsored by Chiesi USA, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations